Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V212 for Herpes Zoster Prevention in Malignancy
NCT01254630Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2011
- Primary completion
- Apr 2017
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of zoster vaccine live in herpes zoster (HZ), sponsored by Merck & Co.. Started Jun 2011; status: completed.
02
Drugs
zoster vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT01254630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254630.